High Detection Rates for Prostate-specific Membrane Antigen–avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography
We investigated a new PET/CT scanner (positron emission tomography/computed tomography) for detection of prostate cancer recurrence. This more sensitive scanner had a higher detection rate, particularly for patients with low PSA (prostate-specific antigen) in their blood. Our results suggest that the new scanner can detect disease recurrence earlier and more accurately than standard PET/CT scanners, which can help in planning further treatment.
Authors
- Paul Conway (ORCID: https://orcid.org/0000-0003-0802-4245)
- Daniel Moon
- Rodney J. Hicks (ORCID: https://orcid.org/0000-0002-0758-0824)
- Hugh Morgan (ORCID: https://orcid.org/0000-0003-3236-0214)
- Jason Callahan (ORCID: https://orcid.org/0000-0002-8957-2560)
- Johanna Ingbritsen
- Robert E. Ware
- Phil Dundee
- Sarah Thomas
- Melissa Munro
Institutions
- Prostate Cancer Foundation of Australia (AU)
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- St Vincent's Hospital Melbourne (AU)
- Melbourne Clinic (AU)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2024-12-07
- DOI
- https://doi.org/10.1016/j.euros.2024.11.008
- Citations
- 5
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.09